A nitric oxide donor intended for in vivo use
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

SE 175

Item No. 82340

Technical Information
Formal Name
2-[[4-[(nitrooxy)methyl]benzoyl]thio]-benzoic acid, methyl ester
CAS Number
258278-64-7
Molecular Formula
C16H13NO6S
Formula Weight
Purity
≥97%
A crystalline solid
DMF: 50 mg/mlDMF:PBS (1:9): 100 µg/mlDMSO: 35 mg/mlEthanol: 11 mg/ml
λmax
205, 243, 278 nm
SMILES
COC(=O)c1ccccc1SC(=O)c1ccc(CO[N](=O)O)cc1
InChi Code
InChI=1S/C16H13NO6S/c1-22-15(18)13-4-2-3-5-14(13)24-16(19)12-8-6-11(7-9-12)10-23-17(20)21/h2-9H,10H2,1H3
InChi Key
JDIVRBDMTYQVOK-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    SE 175 is an organic nitrate compound of the same general class as nitroglycerin. These nitrate compounds can act as NO-donors in vivo following reductive transformation of the nitrate group to nitric oxide. The nitroxyacylated thiosalicylates, such as SE 175, were developed in an effort to facilitate this reductive process and accelerate the release of NO. SE 175 is stable in buffer or saline solution. In the intact rat, it stimulates endothelial soluble guanylate cyclase and induces aortic vasorelaxation with an EC50 of 20 µM, which is intermediate in potency between nitroglycerine and isosorbide dinitrate.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Endres, S., Hacker, A., Noack, E., et alNO-donors, Part 3: Nitrooxyacylated thiosalicylates and salicylates-synthesis and biological activities. Eur. J. Med. Chem. 34, 895-901 (1999).